These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 7799569
1. [Investigation on the treatment of infection due to Mycobacterium Kansasii]. Nakazono T, Sugie T, Ogata H, Mizutani S, Sugita H, Kino T, Wada M. Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569 [Abstract] [Full Text] [Related]
5. [Retreatment of pulmonary tuberculosis--duration of chemotherapy]. Wada M, Seita A, Mori T, Ogata H, Sugie T, Sugita H. Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115 [Abstract] [Full Text] [Related]
7. [Clinical features of pulmonary Mycobacterium kansasii infection: comparison with M. tuberculosis and M. avium complex infection]. Matsushita Y, Niimi A, Tanaka E, Amitani R, Kurasawa T, Kawai M, Kuze F. Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1507-14. PubMed ID: 8121086 [Abstract] [Full Text] [Related]
8. Clinical features and follow up of 302 patients with Mycobacterium kansasii pulmonary infection: a 50 year experience. Maliwan N, Zvetina JR. Postgrad Med J; 2005 Aug; 81(958):530-3. PubMed ID: 16085747 [Abstract] [Full Text] [Related]
9. [Mycobacterium kansasii lung infection associated with myelofibrosis--a case refractory to treatment with antitubercular agents]. Umeda A, Asano K, Kawai A, Nakamura H, Fujita H, Mori M, Yamaguchi K, Kanazawa M. Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Dec; 32(12):1170-4. PubMed ID: 7853774 [Abstract] [Full Text] [Related]
10. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy]. Shigeto E, Murakami I, Yokosaki Y. Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329 [Abstract] [Full Text] [Related]
11. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K. Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [Abstract] [Full Text] [Related]
12. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature]. Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H. Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045 [Abstract] [Full Text] [Related]
13. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Griffith DE, Brown-Elliott BA, Wallace RJ. Clin Infect Dis; 2003 Nov 01; 37(9):1178-82. PubMed ID: 14557961 [Abstract] [Full Text] [Related]
14. [Perspective of pulmonary MAC infection treatment]. Kurashima A. Kekkaku; 2007 Mar 01; 82(3):195-9. PubMed ID: 17444124 [Abstract] [Full Text] [Related]
15. [Tuberculosis in compromised hosts]. Kekkaku; 2003 Nov 01; 78(11):717-22. PubMed ID: 14672050 [Abstract] [Full Text] [Related]
17. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex]. Tsukamura M. Kekkaku; 1991 May 01; 66(5):375-80. PubMed ID: 1875580 [Abstract] [Full Text] [Related]
18. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment]. Kobashi Y, Oka M. Kekkaku; 2008 Dec 01; 83(12):779-84. PubMed ID: 19172823 [Abstract] [Full Text] [Related]
19. [Primary infection type atypical mycobacteriosis (lung infection) in the Fuji City Central Hospital during 1989-94]. Imaizumi T. Kekkaku; 1997 Jun 01; 72(6):415-21. PubMed ID: 9248276 [Abstract] [Full Text] [Related]